Clin Cancer Res 26:274281 Kanamori M, Higa T, Sonoda Y, Murakami S, Dodo M, Kitamura H, Taguchi K, Shibata T, Watanabe M, Suzuki H, Shibahara I, Saito R, Yamashita Y, Kumabe T, Yamamoto M, Motohashi H, Tominaga T (2015) Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients
Strength & Pack Size: 500mcg / 2ml 25 Ampoules
NNMT inhibitor for NAD+ metabolism & cellular energy research
All studies were deliberately reviewed by two investigators to decide whether to be included
It employs mixed methods, combining secondary economic data and primary observation data
As noted earlier, the vast majority of interactions defined so far have been restricted to cell biology studies, some with preclinical confirmation and limited clinical correlation in small patient cohorts